Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AUROBINDO PHARMA vs SUVEN LIFE SCIENCES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AUROBINDO PHARMA SUVEN LIFE SCIENCES AUROBINDO PHARMA/
SUVEN LIFE SCIENCES
 
P/E (TTM) x 23.0 -20.5 - View Chart
P/BV x 2.4 5.8 41.1% View Chart
Dividend Yield % 0.3 0.0 -  

Financials

 AUROBINDO PHARMA   SUVEN LIFE SCIENCES
EQUITY SHARE DATA
    AUROBINDO PHARMA
Mar-23
SUVEN LIFE SCIENCES
Mar-23
AUROBINDO PHARMA/
SUVEN LIFE SCIENCES
5-Yr Chart
Click to enlarge
High Rs71594 762.2%   
Low Rs39745 882.7%   
Sales per share (Unadj.) Rs424.20.6 68,324.5%  
Earnings per share (Unadj.) Rs32.9-5.4 -606.6%  
Cash flow per share (Unadj.) Rs54.1-5.1 -1,056.7%  
Dividends per share (Unadj.) Rs3.000-  
Avg Dividend yield %0.50-  
Book value per share (Unadj.) Rs458.117.2 2,661.5%  
Shares outstanding (eoy) m585.94218.07 268.7%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.3111.8 1.2%   
Avg P/E ratio x16.9-12.8 -132.1%  
P/CF ratio (eoy) x10.3-13.5 -75.8%  
Price / Book Value ratio x1.24.0 30.1%  
Dividend payout %9.10-   
Avg Mkt Cap Rs m325,75315,131 2,152.9%   
No. of employees `000NANA-   
Total wages/salary Rs m35,223186 18,915.5%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m248,554135 183,583.6%  
Other income Rs m2,90684 3,439.3%   
Total revenues Rs m251,460220 114,362.2%   
Gross profit Rs m37,070-1,196 -3,098.5%  
Depreciation Rs m12,44665 19,021.5%   
Interest Rs m1,4055 26,111.5%   
Profit before tax Rs m26,125-1,183 -2,209.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m6,8490-   
Profit after tax Rs m19,277-1,183 -1,629.9%  
Gross profit margin %14.9-883.6 -1.7%  
Effective tax rate %26.20-   
Net profit margin %7.8-873.5 -0.9%  
BALANCE SHEET DATA
Current assets Rs m214,5993,455 6,211.5%   
Current liabilities Rs m114,9381,050 10,943.6%   
Net working cap to sales %40.11,776.0 2.3%  
Current ratio x1.93.3 56.8%  
Inventory Days Days213,948 0.5%  
Debtors Days Days66218 30.1%  
Net fixed assets Rs m176,6681,373 12,865.1%   
Share capital Rs m586218 268.7%   
"Free" reserves Rs m267,8133,535 7,575.8%   
Net worth Rs m268,3993,753 7,151.2%   
Long term debt Rs m6,1900-   
Total assets Rs m392,1254,828 8,121.8%  
Interest coverage x19.6-218.8 -9.0%   
Debt to equity ratio x00-  
Sales to assets ratio x0.60 2,260.4%   
Return on assets %5.3-24.4 -21.6%  
Return on equity %7.2-31.5 -22.8%  
Return on capital %10.0-31.4 -32.0%  
Exports to sales %33.740.4 83.3%   
Imports to sales %15.3839.8 1.8%   
Exports (fob) Rs m83,70355 152,882.9%   
Imports (cif) Rs m38,0601,137 3,347.3%   
Fx inflow Rs m85,48355 156,133.9%   
Fx outflow Rs m41,4471,137 3,645.2%   
Net fx Rs m44,036-1,082 -4,068.9%   
CASH FLOW
From Operations Rs m23,868-1,031 -2,313.9%  
From Investments Rs m-39,778-2,606 1,526.1%  
From Financial Activity Rs m18,1443,955 458.7%  
Net Cashflow Rs m2,298317 723.7%  

Share Holding

Indian Promoters % 48.8 69.6 70.1%  
Foreign collaborators % 3.1 0.0 -  
Indian inst/Mut Fund % 41.3 0.6 7,512.7%  
FIIs % 20.7 0.5 3,837.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 48.2 30.4 158.3%  
Shareholders   241,944 74,003 326.9%  
Pledged promoter(s) holding % 20.1 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AUROBINDO PHARMA With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Aurobindo Pharma vs Suven Life Sciences

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Aurobindo Pharma vs Suven Life Sciences Share Price Performance

Period Aurobindo Pharma Suven Life Sciences S&P BSE HEALTHCARE
1-Day 1.82% 0.30% 1.18%
1-Month 5.96% -2.06% -0.75%
1-Year 113.07% 114.92% 61.82%
3-Year CAGR 7.78% 14.94% 18.16%
5-Year CAGR 7.18% -16.22% 19.79%

* Compound Annual Growth Rate

Here are more details on the Aurobindo Pharma share price and the Suven Life Sciences share price.

Moving on to shareholding structures...

The promoters of Aurobindo Pharma hold a 51.8% stake in the company. In case of Suven Life Sciences the stake stands at 69.6%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Aurobindo Pharma and the shareholding pattern of Suven Life Sciences.

Finally, a word on dividends...

In the most recent financial year, Aurobindo Pharma paid a dividend of Rs 3.0 per share. This amounted to a Dividend Payout ratio of 9.1%.

Suven Life Sciences paid Rs 0.0, and its dividend payout ratio stood at -0.0%.

You may visit here to review the dividend history of Aurobindo Pharma, and the dividend history of Suven Life Sciences.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.